Article | November 4, 2021

Paving The Way Towards Carbon Neutral eCOA Trials

Source: Kayentis
eCOA Resources Overview

COVID-19 led businesses to adopt new practices, including moving many operations online and leading to a positive impact on CO2 emission reductions. The clinical trials industry is no exception and is also able to accommodate such change. The timing is right to introduce additional carbon-efficient solutions to clinical trials. This article explores on how to improve eCOA trials carbon footprint.

To learn more about Kayentis, visit https://www.clinicalleader.com/ecommcenter/kayentis.

 

access the Article!

Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.

Subscribe to Clinical Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Clinical Leader

Please tell us more about you so that we can customize our newsletters to your specific interests:

What topics interest you? (Check all that apply.)

Kayentis